Your browser doesn't support javascript.
loading
Cortical disinhibition in Parkinson's disease.
Ammann, Claudia; Dileone, Michele; Pagge, Cristina; Catanzaro, Valentina; Mata-Marín, David; Hernández-Fernández, Frida; Monje, Mariana H G; Sánchez-Ferro, Álvaro; Fernández-Rodríguez, Beatriz; Gasca-Salas, Carmen; Máñez-Miró, Jorge U; Martínez-Fernández, Raul; Vela-Desojo, Lydia; Alonso-Frech, Fernando; Oliviero, Antonio; Obeso, José A; Foffani, Guglielmo.
Afiliación
  • Ammann C; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Dileone M; CIBERNED, Instituto de Salud Carlos III, Madrid, Spain.
  • Pagge C; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Catanzaro V; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Mata-Marín D; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Hernández-Fernández F; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Monje MHG; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Sánchez-Ferro Á; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Nursing, Villaviciosa de Odón, Madrid, Spain.
  • Fernández-Rodríguez B; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Gasca-Salas C; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Máñez-Miró JU; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Martínez-Fernández R; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Vela-Desojo L; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Alonso-Frech F; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Oliviero A; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
  • Obeso JA; Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain.
  • Foffani G; CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
Brain ; 143(11): 3408-3421, 2020 12 05.
Article en En | MEDLINE | ID: mdl-33141146
In Parkinson's disease, striatal dopamine depletion produces profound alterations in the neural activity of the cortico-basal ganglia motor loop, leading to dysfunctional motor output and parkinsonism. A key regulator of motor output is the balance between excitation and inhibition in the primary motor cortex, which can be assessed in humans with transcranial magnetic stimulation techniques. Despite decades of research, the functional state of cortical inhibition in Parkinson's disease remains uncertain. Towards resolving this issue, we applied paired-pulse transcranial magnetic stimulation protocols in 166 patients with Parkinson's disease (57 levodopa-naïve, 50 non-dyskinetic, 59 dyskinetic) and 40 healthy controls (age-matched with the levodopa-naïve group). All patients were studied OFF medication. All analyses were performed with fully automatic procedures to avoid confirmation bias, and we systematically considered and excluded several potential confounding factors such as age, gender, resting motor threshold, EMG background activity and amplitude of the motor evoked potential elicited by the single-pulse test stimuli. Our results show that short-interval intracortical inhibition is decreased in Parkinson's disease compared to controls. This reduction of intracortical inhibition was obtained with relatively low-intensity conditioning stimuli (80% of the resting motor threshold) and was not associated with any significant increase in short-interval intracortical facilitation or intracortical facilitation with the same low-intensity conditioning stimuli, supporting the involvement of cortical inhibitory circuits. Short-interval intracortical inhibition was similarly reduced in levodopa-naïve, non-dyskinetic and dyskinetic patients. Importantly, intracortical inhibition was reduced compared to control subjects also on the less affected side (n = 145), even in de novo drug-naïve patients in whom the less affected side was minimally symptomatic (lateralized Unified Parkinson's Disease Rating Scale part III = 0 or 1, n = 23). These results suggest that cortical disinhibition is a very early, possibly prodromal feature of Parkinson's disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Corteza Cerebral / Inhibición Neural Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Año: 2020 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Corteza Cerebral / Inhibición Neural Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Año: 2020 Tipo del documento: Article País de afiliación: España